Company / Working Capital per Share
Vivos Therapeutics, Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$2.32
FY2025
5-year range
-$2.32 / $1.36
FY2021-FY2025
Trend
-270.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share changed -271% YoY in FY2025, a notable deviation from the 5-year average annual change of -516%.
Based on SEC 10-K filings.
-2.32 in FY2025.
Declined from $-1.51 to $-2.32 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share decreased 270.9% year-over-year.
- Peak working capital per share was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.32 | -270.9% |
| FY2024 | $1.36 | +190.2% |
| FY2023 | -$1.51 | -2399.7% |
| FY2022 | -$0.06 | -105.5% |
| FY2021 | $1.09 | +7.7% |
| FY2020 | $1.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026